A leader in producing the purest pharmaceutical CBD products and developing innovative therapies for heart disease
Developing CardiolRx for the rapidly growing medicinal cannabinoids market.
Committed to conquering a serious condition that affects more than 26 million people globally.
Cardiol is planning an international clinical study of acute myocarditis, a condition caused by inflammation in heart tissue.
July 29, 2019
June 20, 2019
June 13, 2019
Sign up for our Cardiol Therapeutics newsletter to stay up to date with our most recent news, industry updates and press releases.
By submitting this form, you are consenting to receive marketing emails from: Cardiol Therapeutics Inc., 2275 Upper Middle Road East, Suite 101, Oakville, Ontario, L6H 0C3, CA, http://cardiolrx.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.
Emails are serviced by Mailchimp.